Sanofi
add_icon

Sanofi

3,386.10
-22.00
(-0.65%)
Market Cap
7,798.40 Cr
PE Ratio
19.81
Volume
12,565.00
Day High - Low
3,444.40 - 3,376.50
52W High-Low
6,717.00 - 3,396.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
7,798.40 Cr
EPS
179.46
PE Ratio
19.81
PB Ratio
9.12
Book Value
325.33
EBITDA
507.30
Dividend Yield
3.43 %
Industry
Healthcare
Return on Equity
36.45
Debt to Equity
0.02
Analyst Rating and Forecast
- By Refinitiv from3 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+66.67 %
+66.67 %
Hold
Hold+33.33 %
+33.33 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Sanofi India Limited has issued a public notice regarding the transfer of equity shares to IEPF for shareholders who haven't claimed dividends for seven consecutive years, with June 13, 2026 as the deadline.
neutral
Sanofi India Limited has uploaded the video recording of its investors/analysts call held on February 26, 2026, discussing Q4FY25 and FY25 financial results on its website.
negative
Sanofi India receives tax order from Tamil Nadu Commercial Tax Officer demanding ₹2.37 crore for FY 2021-22, comprising tax, interest and penalty related to Input Tax Credit claims.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,777.10
#1 4,26,385.82
38.21
#1 54,729.00
9.71
#1 10,980
16.07
53.49
6,100.00
1,61,935.83
64.01
9,712.00
18.67
2,191
-1.02
43.80
4,270.20
1,44,522.97
62.70
11,539.40
6.99
1,911
26.24
50.03
1,298.90
1,08,410.14
19.25
33,741.20
16.73
5,725
-15.28
53.38
2,322.50
1,06,091.52
22.06
22,909.50
13.74
3,306
#1 37.44
56.84
1,256.40
1,01,488.45
22.07
28,409.50
7.12
5,291
-57.18
31.85
890.50
89,605.14
#1 17.54
23,511.00
18.55
4,615
-0.32
45.58
2,000.00
82,561.01
45.82
12,744.20
#1 20.90
2,007
7.65
37.22
1,291.40
75,004.72
20.80
32,345.60
9.43
3,484
7.59
60.75
5,257.50
62,861.30
25.87
13,458.30
3.70
2,216
1.90
37.74
Growth Rate
Revenue Growth
-1.34 %
Net Income Growth
-13.96 %
Cash Flow Change
100.30 %
ROE
1.50 %
ROCE
-2.71 %
EBITDA Margin (Avg.)
-6.33 %

Quarterly Financial Results

Quarterly Financials
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
622
572
573
547
579
503
526
529
539
Expenses
368
393
377
370
400
367
404
397
364
EBITDA
254
179
195
177
179
137
122
132
175
Operating Profit %
29 %
24 %
23 %
21 %
22 %
21 %
23 %
23 %
32 %
Depreciation
9
9
9
9
9
9
9
10
10
Interest
0
1
0
0
0
0
0
0
0
Profit Before Tax
244
169
186
167
169
127
113
122
165
Tax
54
46
34
30
33
24
30
31
46
Net Profit
190
123
152
138
137
103
82
91
120
EPS in ₹
82.78
53.37
65.95
59.79
59.31
44.81
35.69
39.64
51.89

Balance Sheet

Balance Sheet
2023
2024
Total Assets
1,715
1,612
Fixed Assets
315
313
Current Assets
1,248
1,127
Capital Work in Progress
16
18
Investments
0
0
Other Assets
1,384
1,281
Total Equity & Liabilities
1,715
1,612
Current Liabilities
651
719
Non Current Liabilities
48
32
Total Equity
1,015
861
Reserve & Surplus
992
838
Share Capital
23
23

Cash Flow

Cash Flow
2023
2024
Net Cash Flow
-610
-111
Investing Activities
38
-180
Operating Activities
230
462
Financing Activities
-878
-392

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
60.40 %
60.40 %
60.40 %
60.40 %
60.40 %
60.40 %
60.40 %
60.40 %
60.40 %
60.40 %
60.40 %
60.40 %
60.40 %
60.40 %
60.40 %
60.40 %
60.40 %
60.40 %
60.40 %
60.40 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
6.80 %
0.00 %
6.11 %
5.81 %
5.78 %
5.63 %
5.57 %
5.61 %
5.57 %
5.55 %
DIIs
17.16 %
17.39 %
17.65 %
19.03 %
18.65 %
18.60 %
18.27 %
19.21 %
19.47 %
19.66 %
21.69 %
22.47 %
23.08 %
22.79 %
22.82 %
22.93 %
23.02 %
23.06 %
22.29 %
21.31 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
6.97 %
7.09 %
7.21 %
7.01 %
7.65 %
7.92 %
8.81 %
9.13 %
9.29 %
8.89 %
8.60 %
8.09 %
7.97 %
8.31 %
8.21 %
8.33 %
8.38 %
8.33 %
9.08 %
10.02 %
Others
15.48 %
15.12 %
14.74 %
13.56 %
13.30 %
13.09 %
12.53 %
11.26 %
10.85 %
11.05 %
2.51 %
9.04 %
2.44 %
2.69 %
2.79 %
2.70 %
2.63 %
2.61 %
2.67 %
2.73 %
No of Share Holders
0
48,465
53,567
51,646
50,916
59,276
64,542
73,734
76,694
71,513
68,598
62,870
61,849
67,662
66,211
66,401
68,196
66,790
71,395
75,813

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 71 84 349 365 490 570 167 117 0.00 0.00
Dividend Yield (%) 1.37 1.44 5.58 4.63 6.53 10.15 2.06 2.04 0.00 0.00

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication8 days ago
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMar 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 27, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceFeb 26, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 26, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 26, 2026
Announcement under Regulation 30 (LODR)-Resignation of DirectorFeb 25, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 25, 2026
Announcement under Regulation 30 (LODR)-Dividend UpdatesFeb 25, 2026
Results For The Year Ended Dec 31 2025Feb 25, 2026
Board Meeting Outcome for Outcome Of The Board Meeting.Feb 25, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Feb 20, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 19, 2026
Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Audited Financial Results And Statements For The Quarter And Financial Year Ended 31St December 2025 And Recommendation Of Final Dividend If Any.Feb 19, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 12, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 09, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 05, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Dec 30, 2025
Closure of Trading WindowDec 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 26, 2025
Please Find Enclosed Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 24, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Dec 22, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 20, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotDec 18, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportDec 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 18, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotNov 17, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 04, 2025
Intimation Of Record DateOct 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 30, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationOct 29, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesOct 29, 2025
Financial Results For The Quarter And Nine Months Ended 30Th September 2025Oct 29, 2025
Board Meeting Outcome for Financials Results For The Quarter Ended 30Th September 2025 And Recommendation Of Interim DividendOct 29, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 27, 2025
Announcement under Regulation 30 (LODR)-CessationOct 27, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held On 27Th October 2025Oct 27, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateOct 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 23, 2025
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Statements For The Quarter And Nine-Months Ended 30Th September 2025 And Declaration Of Interim Dividend For The Year 2025 If Any.Oct 23, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 18, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 13, 2025
Closure of Trading WindowSep 26, 2025
Appointment of Company Secretary and Compliance OfficerSep 25, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerSep 25, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportSep 11, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 23, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 14, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Aditya Birla Sun Life Balanced Advantage Fund Direct-Growth
0.35%
0
0.00%
-0.01%
Aditya Birla Sun Life Consumption Direct Fund-Growth
0.48%
0
0.00%
-0.01%
Aditya Birla Sun Life Dividend Yield Fund Direct-Growth
0.52%
0
0.00%
0.00%
Aditya Birla Sun Life Equity Hybrid '95 Fund Direct-Growth
0.28%
0
0.00%
0.00%
Aditya Birla Sun Life Large Cap Direct Fund-Growth
0.33%
0
0.00%
0.00%
Aditya Birla Sun Life Mid Cap Direct Fund-Growth
0.17%
0
0.00%
0.00%
Aditya Birla Sun Life MNC Fund Direct-Growth
0.53%
0
0.00%
-0.01%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
0.00%
0
0.00%
0.00%
Aditya Birla Sun Life Small Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Angel One Nifty Total Market Index Fund Direct - Growth
0.02%
0
0.00%
0.00%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.26%
0
0.00%
-0.02%
Bandhan Healthcare Fund Direct - Growth
1.35%
0
-0.09%
-0.03%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
0.00%
0
0.00%
0.00%
Baroda BNP Paribas Midcap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Baroda BNP Paribas Small Cap Fund Direct - Growth
0.00%
0
0.00%
0.00%
Baroda BNP Paribas Value Fund Direct - Growth
0.74%
0
0.00%
-0.13%
Groww Nifty Total Market Index Fund Direct - Growth
0.02%
0
0.00%
0.00%
HDFC BSE 500 Index Fund Direct - Growth
0.00%
0
0.00%
0.00%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth
0.50%
0
0.00%
-0.01%
Motilal Oswal Quant Fund Direct-Growth
0.00%
0
0.00%
0.00%
Nippon India Growth Mid Cap Fund Direct- Growth
0.20%
0
0.00%
-0.02%
Nippon India Innovation Fund Direct - Growth
0.71%
0
0.00%
-0.02%

Technical Indicators

RSI(14)
Oversold
17.43
ATR(14)
Less Volatile
78.88
STOCH(9,6)
Oversold
5.10
STOCH RSI(14)
Oversold
6.73
MACD(12,26)
Bearish
-33.64
ADX(14)
Strong Trend
37.48
UO(9)
Bullish
22.58
ROC(12)
Downtrend And Accelerating
-11.47
WillR(14)
Oversold
-98.17

About Sanofi

Sanofi India Limited is a pharmaceutical company primarily engaged in manufacturing and trading drugs and pharmaceuticals. It operates manufacturing facilities in Goa and Ankleshwar, Gujarat, and sells products through independent distributors mainly in India. The company focuses on five therapeutic areas: diabetes, epilepsy, cardiology, allergy, and pain care. Key products...more
Chairperson NameAditya Narayan